NLS Pharmaceutics announces 1-for-40 reverse share split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2024
0mins
Reverse Share Split Announcement: NLS Pharmaceutics will implement a 1-for-40 reverse share split of its common shares, effective September 27, 2024, with trading on Nasdaq starting under the existing symbol "NLSP" but with a new CUSIP Number.
Shareholder Approval and Impact: The reverse split was approved by shareholders on September 18, 2024, reducing the outstanding shares from approximately 46.88 million to about 1.17 million shares.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
